Company
Headquarters: Sydney, NSW, Australia
CEO: Mr. Nam Hoat Chua B.A., BA
A$20.9 Million
AUD as of Jan. 1, 2024
US$14.2 Million
Company | Market Cap (USD) |
---|---|
Novo Nordisk | $461.52 B |
Vertex Pharmaceuticals Incorporated | $107.23 B |
Regeneron Pharmaceuticals, Inc. | $100.01 B |
CSL Limited | $94.74 B |
Marinomed Biotech AG | $73.23 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
Bioxyne Limited, a life sciences and health products company, engages in the research and development, manufacture, and distribution of probiotic active pharmaceutical ingredients, wellbeing and nutritional supplements, and beauty products. The company operates in two segments, Wholesale Sales and Direct Sales. It engages in developing various functional foods and beauty products. The company's products portfolio includes Progastrim PCC, a proprietary probiotic, for general health and immune support; Mymana and ColosNZ, are colostrum and fortified milks for nutrition and immune support; BK18, a dairy based formula with probiotics and vitamins; Allura, a weight management and beauty drink for women; Mustang, a weight management and vitality shake for men; and BEssence, offers beauty range products comprising anti-ageing serum. Bioxyne Limited also offers foaming and toning cleanser, repair oils, and Progastrim, a probiotic dietary supplement for gut and immune health. The company provides its products online, as well as through wholesale and direct sales in Australia, the United States, New Zealand, and Asia. Bioxyne Limited was incorporated in 1998 and is headquartered in Sydney, Australia.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Bioxyne Limited has the following listings and related stock indices.
Stock: ASX: BXN wb_incandescent